PRRI

The UN Convention on Biological Diversity’s (CBD) biosafety negotiations have been the target ofbiotech industry lobbyists and pro-biotech governments from the outset. But some have taken a more subtle approach to their lobbying, hiding their agenda beneath a veneer of public interest. Scrape beneath the surface however and their links to the biotech industry become clear. One such organisation is the Public Research and Regulation Initiative (PRRI) which appeared on the scene after the first biosafety negotiations under the CBD. Apparently independent from industry,this group claims to represent the “public research sector” – but how public is public research when GM is involved? Corporate Europe Observatory exposes PRRI as a corporate driven pro-biotech lobby group on biosafety issues

Subscribe to our newsletter

Next Tuesday, the European Parliament's employment committee will vote on a directive that, quite literally, is a life-and-death issue. On the table: the revision of EU laws to protect workers from cancer-causing substances at work.

The European Parliament voted on the reform of the EU Emissions Trading System (ETS) on 15 February, agreeing to weak annual climate targets and massive new handouts to polluters for another decade.

New study on the Commission's legislative advisory groups highlights a continuing Big Business bias - despite Commission's new rules.

Canadian mining company Gabriel Resources is using an investor-state lawsuit to push through its illegal toxic goldmine in the historical Romanian village of Roşia Montană. The claim foreshadows the multi-billion $ claims which could hit EU member states if the EU-Canada trade deal CETA comes into force.